Acromegaly Market Insights, Epidemiology and Market Forecasts, 2016-2018 & 2027 - ResearchAndMarkets.com

September 27, 2018

DUBLIN--(BUSINESS WIRE)--Sep 27, 2018--The “Acromegaly - Market Insights, Epidemiology and Market Forecast-2027” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Acromegaly - Market Insights, Epidemiology and Market Forecast-2027′ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Acromegaly in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Acromegaly from 2016 to 2027 segmented by seven major markets. The Report also covers the current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

The Acromegaly epidemiology division provides the insights about historical and current patient pool and forecasted trend for 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of The report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Topics Covered:

1. Key Insights

2. Acromegaly Market Overview at a Glance

3. Disease Overview: Acromegaly (ACM)

4. Epidemiology and Patient Population

5. Key Findings

6. 7MM Epidemiology

7. United States Epidemiology

8. EU5 Epidemiology

9. Japan Epidemiology

10. Treatment

11. Unmet Needs

12. Marketed Drug

13. Key Cross Competitors

14. Emerging Drugs

15. Acromegaly: 7 Major Market Analysis

16. The United States: Market Outlook

17. EU5: Market Outlook

18. Japan: Market Outlook

19. Market Drivers

20. Market Barriers

21. Appendix

Companies Mentioned

Ipsen Pharmaceuticals Pharmacia & Upjohn Novartis Ionis Pharmaceuticals Antisense Therapeutics Pharmaspur Aspireo Pharmaceuticals

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/hldbwm/acromegaly_market?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180927005813/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Endocrine and Metabolic Disorders Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/27/2018 02:37 PM/DISC: 09/27/2018 02:36 PM


Update hourly